| Guyan Valley Wellness Center | |
|
5322 Mcclellan Hwy Branchland WV 25506-8725 | |
| (304) 824-5707 | |
| (304) 824-5706 |
| Full Name | Guyan Valley Wellness Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 5322 Mcclellan Hwy, Branchland, West Virginia |
| Authorized Official Name and Position | Lisa Leach (CEO) |
| Authorized Official Contact | 3048245806 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Guyan Valley Wellness Center 7400 Lynn Ave Hamlin WV 25523-1138 Ph: (304) 824-5806 | Guyan Valley Wellness Center 5322 Mcclellan Hwy Branchland WV 25506-8725 Ph: (304) 824-5707 |
| NPI Number | 1255521027 |
|---|---|
| Provider Enumeration Date | 07/27/2007 |
| Last Update Date | 03/08/2023 |
| Medicare PECOS PAC ID | 6204821879 |
|---|---|
| Medicare Enrollment ID | O20080111000489 |
News Archive
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
Congenital heart valve defects appear in 2 percent of all live births, making them the most common type of birth defect. While some of these defects have been linked to specific genetic mutations, the majority have no clearly definable genetic cause, suggesting that epigenetic factors - changes in gene expression versus an alteration in the genetic code - play an important role.
Amedica Corporation, a biomaterial company, announced today that it has entered into a distribution agreement with K2M that will provide surgeons and hospitals in Europe with access to Amedica's Silicon Nitride interbody spinal fusion devices.
Merge Healthcare has combined its expertise in medical imaging and clinical trials management software to launch a complete workflow solution for imaging in clinical trials. The new CIMS solution is the first open platform in the industry that allows organizations involved in clinical trials to transparently execute the imaging portion of the study within the overall electronic trial management solution.
As the UK faces up to a growing obesity crisis among youngsters, a University of Huddersfield expert has told a major conference about a successful project which saw a large number of children not only lose weight but also gain in self-esteem and begin to enjoy exercise, which they had previously grown to hate.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255521027 | NPI | - | NPPES |
| 3810011864 | Medicaid | WV | |
| CA9760 | Other | WV | RR MEDICARE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
Congenital heart valve defects appear in 2 percent of all live births, making them the most common type of birth defect. While some of these defects have been linked to specific genetic mutations, the majority have no clearly definable genetic cause, suggesting that epigenetic factors - changes in gene expression versus an alteration in the genetic code - play an important role.
Amedica Corporation, a biomaterial company, announced today that it has entered into a distribution agreement with K2M that will provide surgeons and hospitals in Europe with access to Amedica's Silicon Nitride interbody spinal fusion devices.
Merge Healthcare has combined its expertise in medical imaging and clinical trials management software to launch a complete workflow solution for imaging in clinical trials. The new CIMS solution is the first open platform in the industry that allows organizations involved in clinical trials to transparently execute the imaging portion of the study within the overall electronic trial management solution.
As the UK faces up to a growing obesity crisis among youngsters, a University of Huddersfield expert has told a major conference about a successful project which saw a large number of children not only lose weight but also gain in self-esteem and begin to enjoy exercise, which they had previously grown to hate.
› Verified 2 days ago